Supplementary Protection Certificate Search
Details
- SPC number
- SPC/GB98/025
- Filing date
- 8 July 1998
Applicant(s) details
- Name
-
Merck Canada Inc.,
- Address
-
16711 Trans-Canada Highway
Kirkland
Quebec
H9H 3L1
Canada
Agent details
- Name
-
Merck & Co. Inc.
- Address
-
Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
Patent details
- Patent number
- EP0480717
- Title
-
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
UK authorisation details
- Authority date
- 15 January 1998
- UK authorisations
Community authorisation details
- Country
- Finland
- Dates and numbers
-
25 August 1997 -
12766
-
25 August 1997 -
12767
Product details
- Product description
-
Montelukast, or a pharmaceutically acceptable salt thereof, preferably montelukast sodium
- Status
- Granted
- 12 November 1998
- Product type
- Medicinal
Life details
- In force date
- 10 October 2011
- Actual expiry date
- 24 August 2012
- Maximum expiry date
- 24 August 2012
- Invalid date
- Lapsed date
- Lapsed status
-
Extension details
- Lodged date
- 18 August 2011
- Granted date
- 3 January 2012
- Refused date
- Revoked date
- Expiry date
- 24 February 2013
- Authorisation number
- PL00025/0412 & 0440
- Authorisation date
- 20 December 2010
Information concerning revocation actions and other legal proceedings on an SPC is included in the Patents Status Information record of the relevant patent.